Dipna Pharmachem Balance Sheet Health
Financial Health criteria checks 3/6
Dipna Pharmachem has a total shareholder equity of ₹249.5M and total debt of ₹179.5M, which brings its debt-to-equity ratio to 71.9%. Its total assets and total liabilities are ₹1.0B and ₹794.1M respectively. Dipna Pharmachem's EBIT is ₹29.5M making its interest coverage ratio 2.1. It has cash and short-term investments of ₹182.0K.
Key information
71.9%
Debt to equity ratio
₹179.50m
Debt
Interest coverage ratio | 2.1x |
Cash | ₹182.00k |
Equity | ₹249.49m |
Total liabilities | ₹794.06m |
Total assets | ₹1.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543594's short term assets (₹1.0B) exceed its short term liabilities (₹635.5M).
Long Term Liabilities: 543594's short term assets (₹1.0B) exceed its long term liabilities (₹158.6M).
Debt to Equity History and Analysis
Debt Level: 543594's net debt to equity ratio (71.9%) is considered high.
Reducing Debt: 543594's debt to equity ratio has reduced from 1176.6% to 71.9% over the past 5 years.
Debt Coverage: 543594's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 543594's interest payments on its debt are not well covered by EBIT (2.1x coverage).